AMYLOIDOSIS
Clinical trials for AMYLOIDOSIS explained in plain language.
Never miss a new study
Get alerted when new AMYLOIDOSIS trials appear
Sign up with your email to follow new studies for AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New chemo formula aims to boost transplant success in blood cancers
Disease control OngoingThis study tests a new, more stable version of the chemotherapy drug melphalan in people with multiple myeloma or AL amyloidosis who are getting a stem cell transplant. The goal is to find the best dose that reaches a target level in the body, while possibly causing fewer side ef…
Matched conditions: AMYLOIDOSIS
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 16, 2026 12:50 UTC
-
New hope for rare heart condition: drug combo under study
Disease control OngoingThis study tests a drug combination (daratumumab plus chemotherapy) in people newly diagnosed with AL amyloidosis, a rare disease where abnormal proteins build up in organs, especially the heart. The main goals are to check heart safety and measure drug levels in different racial…
Matched conditions: AMYLOIDOSIS
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
New scaffold material tested for nerve repair safety
Knowledge-focused OngoingThis study looks at whether a new scaffold material is safe to use when repairing a nerve after a biopsy. Twenty adults with various nerve conditions will have a nerve biopsy, and some will get the scaffold graft while others will not. The goal is to see if the graft reduces pain…
Matched conditions: AMYLOIDOSIS
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:06 UTC